Patents Examined by Anna Skibinsky
  • Patent number: 11710538
    Abstract: The efficiency of polymer synthesis is increased by reducing the number of monomer addition cycles needed to create a set of polymer strands. The number of cycles depends on the sequences of the polymer strands and the order in which each type of monomer is made available for addition to the growing strands. Efficiencies are created by grouping the polymer strands into batches such that all the strands in a batch require a similar number of cycles to synthesize. Efficiencies are also created by selecting an order in which the monomers are made available for addition to the growing polymer strands in a batch. Both techniques can be used together. With these techniques, the number of cycles of monomer addition and commensurate reagent use may be reduced by over 10% as compared to naïve synthesis techniques.
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: July 25, 2023
    Assignee: MICROSOFT TECHNOLOGY LICENSING, LLC
    Inventors: Sergey Yekhanin, Miklos Racz, Konstantin Makarychev, Cyrus A. Rashtchian, Karin Strauss, Bichlien Hoang Nguyen
  • Patent number: 11710539
    Abstract: A method is disclosed for predicting in advance whether a melanoma patient is likely to benefit from high dose IL2 therapy in treatment of the cancer. The method makes use of mass spectrometry data obtained from a blood-based sample of the patient and a computer configured as a classifier and making use of a reference set of mass spectral data obtained from a development set of blood-based samples from other melanoma patients. A variety of classifiers for making this prediction are disclosed, including a classifier developed from a set of blood-based samples obtained from melanoma patients treated with high dose IL2 as well as melanoma patients treated with an anti-PD-1 immunotherapy drug. The classifiers developed from anti-PD-1 and IL2 patient sample cohorts can also be used in combination to guide treatment of a melanoma patient.
    Type: Grant
    Filed: January 18, 2017
    Date of Patent: July 25, 2023
    Assignee: BIODESIX, INC.
    Inventors: Arni Steingrimsson, Carlos Oliveira, Krista Meyer, Joanna Röder, Heinrich Röder
  • Patent number: 11702708
    Abstract: The invention provides systems and methods for analyzing viruses by representing viral genetic diversity with a directed acyclic graph (DAG), which allows genetic sequencing technology to detect rare variations and represent otherwise difficult-to-document diversity within a sample. Additionally, a host-specific sequence DAG can be used to effectively segregate viral nucleic acid sequence reads from host sequence reads when a sample from a host is subject to sequencing. Known viral genomes can be represented using a viral reference DAG and the viral sequence reads from the sample can be compared to viral DAG to identify viral species or strains from which the reads were derived. Where the viral sequence reads indicate great genetic diversity in the virus that was infecting the host, those reads can be assembled into a DAG that itself properly represents that diversity.
    Type: Grant
    Filed: July 24, 2020
    Date of Patent: July 18, 2023
    Assignee: Seven Bridges Genomics Inc.
    Inventors: Devin Locke, Piotr Szamel
  • Patent number: 11699527
    Abstract: Methods for improving clinical diagnostic tests are provided, along with associated diagnostic techniques.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: July 11, 2023
    Assignee: Otraces, Inc.
    Inventors: Galina Krasik, Mohsen Marefat, Keith Lingenfelter
  • Patent number: 11697835
    Abstract: The invention provides systems and methods for determining patterns of modification to a genome of a subject by representing the genome using a graph, such as a directed acyclic graph (DAG) with divergent paths for regions that are potentially subject to modification, profiling segments of the genome for evidence of epigenetic modification, and aligning the profiled segments to the DAG to determine locations and patterns of the epigenetic modification within the genome.
    Type: Grant
    Filed: September 16, 2020
    Date of Patent: July 11, 2023
    Assignee: Seven Bridges Genomics Inc.
    Inventors: Devin Locke, Wan-Ping Lee
  • Patent number: 11692174
    Abstract: Described herein are various systems, methods, and apparatus for systematic creation of isolated homogeneous colonies of cells from vector-based lineages. The vector-based lineages may originate from multiple types of viral vector families (e.g., Paramyx-oviridae, Retroviridae, Parvoviridae) or non-natural engineered vectors or a plurality of vector combinations, for example. In certain embodiments, the isolated homogeneous colonies of cells are vector-free sub-colonies; in other embodiments, the isolated homogeneous colonies of cells are homogeneous vector sub-colonies. In other embodiments, vector mixed sub-colonies are created. The disclosed systems, methods, and apparatus are useful for inducible pluripotent stem cell (iPSC) production and work by selectively binding to one or more corresponding protein markers expressed on the surface of a cell that indicate that cellular reprogramming has occurred. Software is used to automate the purification and isolation of the iPSCs produced.
    Type: Grant
    Filed: February 8, 2018
    Date of Patent: July 4, 2023
    Assignee: Sapphiros AI Bio LLC
    Inventors: Robin Y. Smith, Marcie A. Glicksman
  • Patent number: 11688489
    Abstract: Disclosed herein are systems and methods for collapsing sequencing reads and identifying similar sequencing reads. In one example, a method includes generating a plurality of first identifier subsequences from a first identifier sequence of each nucleotide sequencing read and generating a first signature for the nucleotide sequencing read by applying hashing to the plurality of first identifier subsequences. The method may include assigning the nucleotide sequencing read to a first particular bin of a first data structure based on the first signature and determining a nucleotide sequence for each first particular bin of the first data structure with one or more nucleotide sequencing reads assigned.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: June 27, 2023
    Assignee: Illumina, Inc.
    Inventors: Chen Zhao, Kevin Eric Wu, Sven Bilke
  • Patent number: 11670399
    Abstract: The disclosed technology provides a computational prediction modeling comprising a novel algorithm for prediction of glycosylation or to optimize biopharmaceutical production of proteins of therapeutic relevance. The model of the disclosed technology can be used to predict glycosylation changes based solely on the stating glycoprofiles in any host cells and known or suggested rules on enzyme specificity. Applications of the invention model are also provided.
    Type: Grant
    Filed: May 18, 2016
    Date of Patent: June 6, 2023
    Assignee: The Regents of the University of California
    Inventors: Philipp N. Spahn, Nathan E. Lewis
  • Patent number: 11657120
    Abstract: A method and an apparatus for determining at least one smoothed data point (tk, sk) within a stream of data points {ti, si} with 1?i?z, k<z is disclosed. Herein, the stream of data points {ti, si} is consecutively acquired in a manner that a data point (ti, si) is acquired after an acquisition of a preceding data point (ti?1, si?1), wherein each data point (ti, si) comprises a valid value or an invalid value or a missing value for the signal si at a time ti. Herein, the signal si at the time ti comprises physical, chemical, biological, environmental, and/or technical data acquired by means of a technical set-up. According to the method, a set of data points is provided, wherein for each smoothed data point (tk, sk) a smoothing set is created. For each smoothed data point (tk, sk), trailing data resulting from large gaps are removed until it is verified whether the smoothing set comprises a minimal number of data points.
    Type: Grant
    Filed: October 25, 2019
    Date of Patent: May 23, 2023
    Assignee: EyeSense AG
    Inventors: Frank Küster, Roland Krivànek, Achim Müller
  • Patent number: 11649495
    Abstract: The invention provides methods of analyzing an individual's mtDNA by transforming available reference sequences into a directed graph that compactly represents all the information without duplication and comparing sequence reads from the mtDNA to the graph to identify the individual or describe their mtDNA. A directed graph can represent all of the genetic variation found among the mitochondrial genomes across all of a number of reference organisms while providing a single article to which sequence reads can be aligned or compared. Thus any sequence read or other sequence fragment can be compared, in a single operation, to the article that represents all of the reference mitochondrial sequences.
    Type: Grant
    Filed: February 24, 2020
    Date of Patent: May 16, 2023
    Assignee: Seven Bridges Genomics Inc.
    Inventors: Devin Locke, Piotr Szamel
  • Patent number: 11646099
    Abstract: In embodiments of the invention, the invention provides a method for distinguishing between lymphoma types based on gene expression measurements. In embodiments, the invention distinguishes between PMBCL and DLBCL based on gene expression signatures, and can further distinguish between DLBCL subtypes. In embodiments of the invention, the distinctions are used in methods of treatment.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: May 9, 2023
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, British Columbia Cancer Agency, Mayo Foundation for Medical Education and Research, Julius-Maximilians-University of Würzburg, Boatd of Regents of the University of Nebraska, Oslo University Hospital HF, Hospital Clinic de Barcelona, Universitat de Barceloa, Institut D'Investigacions Biomédiques Pi I Sunyer (IDIBAPS), Robert Bosch Gesellschaft feuer medizinische Forshung mbH, Oregon Health & Science University, City of Hope, The Cleveland Clinic Foundation
    Inventors: Louis M. Staudt, Christian Steidl, Anja Mottok, George W. Wright, David William Scott, Lisa M. Rimsza, Andreas Rosenwald, Randy Gascoyne, Timothy Greiner, Dennis Weisenburger, Erlend B. Smeland, Jan Delabie, Elias Campo Guerri, German Ott, Rita Braziel, Elaine S. Jaffe, Kai Fu, Wing C. Chan, Joo Song, James R. Cook
  • Patent number: 11639936
    Abstract: A normal set of cells is characterized using flow cytometry. A centroid and radius are defined for a set of clusters in an n-dimensional space corresponding to a normal maturation for a cell lineage in the normal set of cells. A test set of cells is characterized using flow cytometry and the characterization is compared to the defined set of clusters. Support Vector Machine (SVM) subroutines are employed to identify reference populations of interest by generating multidimensional boundary definitions. These boundary definitions may be used to identify reference populations to use in defining or refining a centroid line or a radius or radii defining a set of normal clusters, and to characterize and compare a test set of cells to the defined set of normal clusters.
    Type: Grant
    Filed: September 19, 2017
    Date of Patent: May 2, 2023
    Assignee: Hematologics, Inc.
    Inventors: Michael R. Loken, Andrew P. Voigt
  • Patent number: 11621053
    Abstract: Methods and systems are described for identification and characterization of allosteric sites in proteins and enzyme molecules. The disclosed methods allow for identification of natural and true binding sites on surface regions of protein and enzyme molecules by following the pathways of energy flow between the activity center to the surface regions. Allosteric sites are identified and ranked for their effect on target activity of the protein using computational methods. Then chemical libraries are screened to find the best candidates for drug like molecules that affect target activity of the protein or enzyme.
    Type: Grant
    Filed: October 11, 2019
    Date of Patent: April 4, 2023
    Assignee: Arium BioLabs LLC
    Inventor: Pratul K Agarwal
  • Patent number: 11609917
    Abstract: A system and method for extrapolating a set of specific representational identifiers that are represented or covered by a generic representational identifier found in a target document. Queries are constructed and performed on a corpus of source documents in which members of the extrapolated set of specific representational identifiers are compared to a database of representational data. By matching representational data in this way, any overlap between the generic representational data and specific instances of the generic representational identifier within the source documents is determined. In a more specific implementation, the system and method reduces the scope of the generic representational identifier such that the reduced scope generic representational identifier encompasses only novel specific representational identifiers.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: March 21, 2023
    Assignee: ACCENCIO LLC
    Inventors: Paul Blake, Kevin Brogle, Kevin Brown, Don Kyle
  • Patent number: 11574704
    Abstract: The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: February 7, 2023
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, British Columbia Cancer Agency Branch, Arizona Board of Regents on Behalf of the University of Arizona, Universitat de Barcelona, Hospital Clinic de Barcelona
    Inventors: Louis M. Staudt, George W. Wright, David William Scott, Joseph M. Connors, Randy D. Gascoyne, Lisa Rimsza, Elias Campo Guerri, Raymond Tubbs, Timothy C. Greiner, James Robert Cook, Kai Fu, Paul Michael Williams, Chih-Jian Lih, Elaine S. Jaffe, Rita M. Braziel, Andreas Rosenwald, Erlend B. Smeland, Wing C. Chan, German Ott, Jan Delabie, Dennis Weisenburger
  • Patent number: 11574404
    Abstract: Embodiments include controlling a processor to perform operations, the operations comprising accessing a digitized image of a region of tissue (ROT) demonstrating cancerous pathology; extracting a set of radiomic features from the digitized image, where the set of radiomic features are positively correlated with programmed death-ligand 1 (PD-L1) expression; providing the set of radiomic features to a machine learning classifier; receiving, from the machine learning classifier, a probability that the region of tissue will experience cancer recurrence, where the machine learning classifier computes the probability based, at least in part, on the set of radiomic features; generating a classification of the region of tissue as likely to experience recurrence or non-recurrence based, at least in part, on the probability; and displaying the classification and at least one of the probability, the set of radiomic features, or the digitized image.
    Type: Grant
    Filed: February 18, 2019
    Date of Patent: February 7, 2023
    Assignees: Case Western Reserve University, The Cleveland Clinic Foundation
    Inventors: Anant Madabhushi, Pranjal Vaidya, Kaustav Bera, Prateek Prasanna, Vamsidhar Velcheti
  • Patent number: 11568957
    Abstract: Methods and systems for determining copy number variants are disclosed. An example method can comprise applying a sample grouping technique to select reference coverage data, normalizing sample coverage data comprising a plurality of genomic regions, and fitting a mixture model to the normalized sample coverage data based on the selected reference coverage data. An example method can comprise identifying one or more copy number variants (CNVs) according to a Hidden Markov Model (HMM) based on the normalized sample coverage data and the fitted mixture model. An example method can comprise outputting the one or more copy number variants.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: January 31, 2023
    Assignee: Regeneron Pharmaceuticals Inc.
    Inventors: Jeffrey Reid, Lukas Habegger, Jonathan Packer, Evan Maxwell
  • Patent number: 11545235
    Abstract: In accordance with an embodiment of the invention, a system and method is provided for determining a probability of a progeny having one or more phenotypes Phj each associated with a single gene Qj. A score sip may be assigned to each allele hip at a plurality of genetic loci (i) in a haploid genome profile Hp of a parent (p). A plurality (Nj) of the alleles hkp (k=1, . . . , Nj) associated with the gene Qj may be identified. The scores sip may be mapped or indexed to gene-specific scores ?j,kp associated with gene Qj for the plurality of (Nj) alleles hkp. A probability may be computed for altering the gene product from gene Qj in a progeny of the parent (p) to be a function of the gene-specific scores ?j,kp.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: January 3, 2023
    Assignee: Ancestry.com DNA, LLC
    Inventors: Lee M. Silver, Adam Cohn, Ari Julian Silver
  • Patent number: 11532379
    Abstract: The present invention comprises the capture and display of arthropod, human and arthropod-based metadata, which is capable of tracking and displaying the metadata, which is time and location-based, in order to show migration paths of arthropods and/or the diseases they have the potential to carry. This real-time view can help predict future arthropod and disease based on various scenarios such as, but not limited to: increased exposure based on the following: a user's geo-location, date and/or time of year, carrier type, etc. These variables can then assist with the education, awareness and potential prevention of disease.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: December 20, 2022
    Assignee: THE LIVLYME FOUNDATION
    Inventors: Olivia Newell Goodreau, Holiday Grogan Goodreau, Matthew S. Fox, Jeffrey A. Stauffer, Sean P. Cowan, Gregory J. Maddox, Wilson P. Bridgett, Stephanie A. Perkins
  • Patent number: 11527304
    Abstract: A computer-implemented method for inferring genetic ancestry from low-coverage genomic data may include (i) generating a reference matrix representing a genetic reference panel in terms of dosages for given reference samples at given loci, (ii) decomposing the reference matrix via non-negative matrix factorization into an ancestral genotype matrix and an ancestral attribution matrix, (iii) resampling the reference matrix, (iv) deriving an ancestral alternate reads matrix that, when multiplied with the ancestral attribution matrix, approximates the resampled reference matrix, (v) deriving an ancestral attribution vector that, when multiplied with the ancestral alternate reads matrix, approximates a vector representing the test sample, and (vi) determining the genetic ancestry of the subject based on the ancestral attribution vector. Various other methods, systems, and computer-readable media are also disclosed.
    Type: Grant
    Filed: July 26, 2019
    Date of Patent: December 13, 2022
    Assignee: MYRIAD WOMEN'S HEALTH, INC.
    Inventors: Kristjan Eerik Kaseniit, Imran Saeedul Haque